BMED ETF — BlackRock Future Health ETF

BlackRock Future Health ETF (BMED)

Updated October 16, 2026.

BMED is an ETF. its trailing-12-month yield is 0.23%, its expense ratio is 0.55%. Dividend Vision Distribution Safety Score™ is 50/100 (Unproven). Total return is 35.8% over the past 6 years, 109.7 points behind SPY at 145.5%.

BlackRock Future Health ETF is an equity fund that invests at least 80% of its assets in companies engaged in health sciences industries, including those providing products and services for human and animal health. The fund carries a low expense ratio of 0.55% and distributes annually; note that its latest distribution was special and may not recur regularly. The fund appeals to equity investors seeking exposure to healthcare and life sciences sectors.

BMED performance versus SPY

Price and return data through 2026-10-16.

Total return is 35.8% over the past 6 years, 109.7 points behind SPY at 145.5%. Over the past year its total return — price change plus distributions reinvested — is 24.1%. Its deepest 1-year drawdown was 14.9%.

BMED key facts

Distribution Safety Score™

50 · Unproven

Issuer

BlackRock

Asset type

ETF

Asset class

Equity

Inception date

09/29/2020

Expense ratio

0.55%

Distribution frequency

Annual

Trailing yield

0.23%

Last close

$34.55 (as of 2026-10-16)

AUM

$14,034,244

Average volume

2112.0

Dividend

$0.081

Ex-dividend date

06/15/2026

Payment date

06/18/2026

Beta

0.7

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (0.23%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: BlackRock; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

BMED risks and drawbacks

Payments are annual, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 14.9%.

Who may consider BMED — and who may not

It is a weaker fit for investors who need monthly cash flow (BMED pays annual); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on BMED

• All tickers starting with B

Frequently asked questions

More securities from BlackRock.